The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations
- PMID: 17438087
- DOI: 10.1158/1078-0432.CCR-07-0086
The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations
Comment on
-
Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.Clin Cancer Res. 2007 Apr 15;13(8):2378-84. doi: 10.1158/1078-0432.CCR-06-1900. Clin Cancer Res. 2007. PMID: 17438096
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
